Forte Biosciences

About:

Forte Biosciences is a biotechnology company that focuses on dermatology.

Website: https://www.fortebiorx.com/home/default.aspx

Top Investors: The Red Hook Fund LP, OrbiMed, Perceptive Advisors, Biotechnology Value Fund, Janus Henderson Investors

Description:

Forte Biosciences is a biotechnology company that focuses on dermatology. The company's lead product, FB-401, is a topically applied live biotherapeutic developed in collaboration with the National Institutes of Health and the National Institute of Allergy and Infectious Diseases for the treatment of inflammatory skin disease.

Total Funding Amount:

$124M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Sherman Oaks, California, United States

Founded Date:

2017-01-01

Contact Email:

inquiry(AT)fortebiorx.com

Founders:

Paul Wagner

Number of Employees:

1-10

Last Funding Date:

2024-11-20

IPO Status:

Public

Industries:

© 2025 bioDAO.ai